MiMedx Group, Inc.
MDXG
$4.27
$0.071.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 355.17M | 389.42M | 418.63M | 393.44M | 363.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 355.17M | 389.42M | 418.63M | 393.44M | 363.77M |
| Cost of Revenue | 75.12M | 73.82M | 73.01M | 70.87M | 67.47M |
| Gross Profit | 280.05M | 315.59M | 345.62M | 322.58M | 296.30M |
| SG&A Expenses | 255.08M | 259.46M | 266.19M | 254.21M | 239.37M |
| Depreciation & Amortization | 833.00K | 642.00K | 440.00K | 504.00K | 584.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 346.42M | 349.83M | 354.74M | 339.48M | 320.55M |
| Operating Income | 8.75M | 39.59M | 63.89M | 53.96M | 43.23M |
| Income Before Tax | 11.53M | 42.32M | 66.26M | 55.72M | 44.29M |
| Income Tax Expenses | 5.29M | 11.62M | 17.68M | 14.89M | 12.33M |
| Earnings from Continuing Operations | 6.24 | 30.70 | 48.58 | 40.83 | 31.96 |
| Earnings from Discontinued Operations | -- | -- | -- | 0.00 | 217.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.24M | 30.70M | 48.58M | 40.83M | 32.17M |
| EBIT | 8.75M | 39.59M | 63.89M | 53.96M | 43.23M |
| EBITDA | 20.41M | 52.88M | 78.77M | 68.61M | 53.75M |
| EPS Basic | 0.04 | 0.21 | 0.33 | 0.28 | 0.22 |
| Normalized Basic EPS | 0.05 | 0.18 | 0.28 | 0.24 | 0.19 |
| EPS Diluted | 0.04 | 0.20 | 0.32 | 0.27 | 0.21 |
| Normalized Diluted EPS | 0.05 | 0.18 | 0.28 | 0.23 | 0.19 |
| Average Basic Shares Outstanding | 592.37M | 592.33M | 591.16M | 590.08M | 589.00M |
| Average Diluted Shares Outstanding | 596.14M | 597.67M | 598.90M | 597.95M | 596.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |